Specifications
- Purity
- ≥98% (HPLC)
- Appearance
- White to off-white powder
- Identity
- 1H-NMR
Properties
- Solvents
- Soluble in DMSO (20mg/ml).
- Melting Point
- 211-214 °C (lit.)
Category: Steroids
For Research Use Only. Not Intended for Diagnostic or Therapeutic Use.
Hydrocortisone is a glucocorticoid produced by the adrenal cortex in response to adrenocorticotropic hormone (ACTH). Hydrocortisone has three times the anti-inflammatory potency of corticosterone but much lower Na+ retention potency. It is an agonist at the mineralocorticoid receptor (MR) and the glucocorticoid receptor. Hydrocortisone plays a role in the regulation of metabolism, electrolyte balance, water balance, and the body′s stress response. Hydrocortisone production is increased during periods of stress, and it is a major effector molecule in the hypothalamic-pituitary-adrenal axis (HPA) stress response. Cortisol levels increase with age and are often elevated in major depressive disorder, certain forms of hypertension, and Parkinson’s disease. It has been utilized in research to investigate the impact of inflammation and stress on cellular processes.
| Synonyms | 11&beta,17&alpha, 21-Trihydroxypregn-4-ene-3,20-dione, Cortisol, Dihydrocostisone, NSC 10483, Kendall’s compound F, Reichstein’s substance M |
|---|---|
| Purity | ≥98% (HPLC) |
| Appearance | White to off-white powder |
| CAS-Number | 50-23-7 |
| Molecular Formula | C21H30O5 |
| Molecular Weight | 362.46 |
| Identity | 1H-NMR |
| Solvents | Soluble in DMSO (20mg/ml). |
| Melting Point | 211-214 °C (lit.) |
| Smiles | O=C1CC[C@@]2(C)C(CC[C@]3([H])[C@]2([H])[C@@H](O)C[C@@]4(C)[C@@]3([H])CC[C@]4(O)C(CO)=O)=C1 |
| InChi Key | JYGXADMDTFJGBT-VWUMJDOOSA-N |
| Shipping | AMBIENT |
| Short Term Storage | RT |
| Long Term Storage | RT |
| Handling Advice | Protect from light and moisture. |
| Use / Stability | Stable for at least 2 years after receipt when stored at RT. |
| Hazard statements | H360Df – H373 |
| Precautionary statements | P202 – P260 – P280 – P308 + P313 – P405 – P501 |
| GHS Symbol | GHS08 |
| Signal word | Danger |
| Transportation | Not dangerous goods |
| References | (1) D.T. Matulich, et al.; J. Clin. Endocrinol. Metab. 43, 1170 (1976), (2) P.E. Stokes; Eur. Neuropsychopharmacol. 5, 77 (1995), (3) F.P. Varghese & E.S. Brown; Prim. Care Companion. J. Clin. Psychiatry 3, 151 (2001), (4) M. Quinkler & P.M. Stewart; J. Clin. Endocrinol. Metab. 88, 2384 (2003), (5) J. Nijm & L. Jonasson; Ann. Med. 41, 224 (2009), (6) S. Paredes & L. Ribeiro; Rev. Assoc. Med. Bras. 60, 84 (2014), (7) D.J. van Wamelen, et al.; Int. Rev. Neurobiol. 152, 131 (2020) |
| InChi | InChI=1S/C21H30O5/c1-19-7-5-13(23)9-12(19)3-4-14-15-6-8-21(26,17(25)11-22)20(15,2)10-16(24)18(14)19/h9,14-16,18,22,24,26H,3-8,10-11H2,1-2H3/t14-,15-,16-,18+,19-,20-,21-/m0/s1 |
| Quantity | 1 g, 5 g, 25 g, Bulk |

(2-Hydroxypropyl)-β-cyclodextrin